Regen BioPharma Inc logo

Regen BioPharma Inc

RGBP · OTC · Health Technology, Biotechnology · Founded 2012

Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders.

Current Price
—
Market Cap
—
Return Since Last Split
-100%
Last Split
Nov 4, 2024
Total Splits
1
Cumulative Multiple
2×

What If You Bought RGBP Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Nov 4, 2024$0.122-for-12×2×

Regen BioPharma Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Regen BioPharma Inc's latest record in the split calendar is a 2-for-1 forward split effective 2024-11-04.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.